Home · Peptides · Zhenoluten
THE PEPTIDE APP FIELD GUIDE · Longevity SERIES FIELD SPECIMEN
Longevity CATEGORY

Zhenoluten

THE OVARIAN RESTORER

A-15 Ovary Bioregulator Peptide

Zhenoluten is a bioregulator peptide derived from ovarian tissue that helps restore hormonal balance and ovarian function. It works by enhancing the genes that control follicular development and hormone production. Particularly valuable for women experiencing premature ovarian decline, perimenopause, or fertility challenges.

Zhenoluten
Zhenoluten
Zhenoluten

Zhenoluten Evidence Snapshot

How these guides are reviewed
REGULATORY STATUS

Not FDA approved · research use only

DOSING GUIDANCE

Reviewed by our clinical team

LINKED EVIDENCE

1 research sources

CONTENT UPDATED

Aug 28, 2026

Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.

Quick Answers About Zhenoluten

◆

Is Zhenoluten FDA approved

No. This profile records Zhenoluten as not FDA approved and for research use only.

MORE CONTEXT ›

Review the regulatory and source details on this page for the current context.

◆

What dose does The Peptide App Clinical Team recommend for Zhenoluten?

Dose: 20 mg orally each morning.

MORE CONTEXT ›

Schedule: daily. Cycle: 4 weeks on, 12 weeks off. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.

◆

What research supports this Zhenoluten guide?

This guide links to 1 curated or current research sources.

MORE CONTEXT ›

Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.

Studied Effects & Mechanisms

Follicular Development

Upregulates GDF9, BMP15, and FOXL2 for healthy follicle maturation

Hormone Synthesis

Increases STAR and CYP19A1 for enhanced estrogen/progesterone production

HPO Axis Restoration

Restores hypothalamic-pituitary-ovarian signaling via epigenetic modification

Women with premature ovarian insufficiency
Those experiencing perimenopause symptoms
Women with irregular menstrual cycles
Those wanting to support fertility naturally
Women wanting to protect ovarian health during aging

Zhenoluten Research

Live research temporarily unavailable

The live research feed did not return papers for this page. The curated references below remain available for crawlable source context.